Drug development company NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) is not ready to give up on EmtinB, its trademark drug that…
After the Human Research Ethics Committee (HREC) rejected the Company’s flagship drug, EmtinB, knocking back years of research in the…
Aussies suffering from Alzheimer’s disease may have avoided some sketchy science after drug development company Neuroscientific Biopharmaceuticals (ASX: NSB) had…
The 60 million individuals around the world who suffer from glaucoma could one day have a cure for the debilitating…
With the average person’s life expectancy rising, Alzheimer's disease is emerging as a major health concern which can have devastating…